190 related articles for article (PubMed ID: 7960217)
1. Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte/macrophage colony-stimulating factor in combination.
Lord BI; Testa NG; Bretti S; Chang J; Demuynck H; Coutinho L; de Campos E; Fitzsimmons L; Scarffe JH
Int J Cancer; 1994 Nov; 59(4):483-90. PubMed ID: 7960217
[TBL] [Abstract][Full Text] [Related]
2. Myeloid cell kinetics in response to haemopoietic growth factors.
Lord BI
Baillieres Clin Haematol; 1992 Jul; 5(3):533-50. PubMed ID: 1281018
[TBL] [Abstract][Full Text] [Related]
3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
5. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
6. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo.
Lord BI; Molineux G; Pojda Z; Souza LM; Mermod JJ; Dexter TM
Blood; 1991 May; 77(10):2154-9. PubMed ID: 1709372
[TBL] [Abstract][Full Text] [Related]
7. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
8. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin.
Brugger W; Bross K; Frisch J; Dern P; Weber B; Mertelsmann R; Kanz L
Blood; 1992 Mar; 79(5):1193-200. PubMed ID: 1371415
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
11. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
13. Haemopoietic cell kinetics in humans treated with rGM-CSF.
Lord BI; Gurney H; Chang J; Thatcher N; Crowther D; Dexter TM
Int J Cancer; 1992 Jan; 50(1):26-31. PubMed ID: 1370226
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.
Aglietta M; Pasquino P; Sanavio F; Stacchini A; Severino A; Fubini L; Morelli S; Volta C; Monteverde A; Piacibello W
Stem Cells; 1993 Jul; 11 Suppl 2():83-7. PubMed ID: 8401260
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin-3 pretreatment on granulocyte/macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor cells.
Geissler K; Peschel C; Niederwieser D; Goldschmitt J; Hladik F; Fritz A; Ohler L; Bettelheim P; Huber C; Lechner K
Br J Haematol; 1995 Oct; 91(2):299-305. PubMed ID: 8547065
[TBL] [Abstract][Full Text] [Related]
16. Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
Vadhan-Raj S; Broxmeyer HE; Hittelman WN; Papadopoulos NE; Chawla SP; Fenoglio C; Cooper S; Buescher ES; Frenck RW; Holian A
J Clin Oncol; 1992 Aug; 10(8):1266-77. PubMed ID: 1634916
[TBL] [Abstract][Full Text] [Related]
17. Induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) expression in bone marrow and fractionated marrow cell populations by interleukin 3 (IL-3): IL-3-mediated positive feedback mechanisms of granulopoiesis.
Tsuji T; Sugimoto K; Yanai T; Takashita E; Mori KJ
Growth Factors; 1994; 11(1):71-9. PubMed ID: 7530467
[TBL] [Abstract][Full Text] [Related]
18. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
[TBL] [Abstract][Full Text] [Related]
19. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA
Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936
[TBL] [Abstract][Full Text] [Related]
20. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
